Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin Choy

Showing results (21-30 of 180) with videos related to

Pageof 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2017
Expression and Therapeutic Potential of SOX9 in ChordomaHua Chen, Cassandra C Garbutt, Dimitrios Spentzos, et al.
Journal of Biomolecular Screening|February 13, 2010
Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assayMichiro Susa, Edwin Choy, Cao Yang, et al.
Cancer Chemotherapy and Pharmacology|December 25, 2015
p53 overexpression increases chemosensitivity in multidrug-resistant osteosarcoma cell linesShunan Ye, Jacson Shen, Edwin Choy, et al.
Discovery Medicine|December 10, 2015
The emerging roles and therapeutic potential of microRNAs (miRs) in liposarcomaRanran Sun, Jacson K Shen, Edwin Choy, et al.
The New England Journal of Medicine|August 25, 2016
CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 26-2016. A 28-Year-Old Woman with Back Pain and a Lesion in the Lumbar SpineEdwin Choy, Francis J Hornicek, Yen-Lin Chen, et al.
Cancer|October 19, 2011
High-throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide-3-kinase and other oncogenesEdwin Choy, Francis Hornicek, Laura MacConaill, et al.
Molecular Cancer Therapeutics|June 14, 2011
MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migrationZhenfeng Duan, Edwin Choy, David Harmon, et al.
Cancer Letters|January 26, 2016
Development and potential applications of CRISPR-Cas9 genome editing technology in sarcomaTang Liu, Jacson K Shen, Zhihong Li, et al.
The New England Journal of Medicine|October 23, 2014
Case records of the Massachusetts General Hospital. Case 33-2014. A 60-year-old man with bone painEdwin Choy, Eyal C Attar, Kevin S Oh, et al.
Molecular Cancer Therapeutics|October 1, 2010
Cyclin G-associated kinase is necessary for osteosarcoma cell proliferation and receptor traffickingMichiro Susa, Edwin Choy, Xianzhe Liu, et al.
Pageof 18

Showing results (21-30 of 180) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2017
Expression and Therapeutic Potential of SOX9 in ChordomaHua Chen, Cassandra C Garbutt, Dimitrios Spentzos, et al.
Journal of Biomolecular Screening|February 13, 2010
Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assayMichiro Susa, Edwin Choy, Cao Yang, et al.
Cancer Chemotherapy and Pharmacology|December 25, 2015
p53 overexpression increases chemosensitivity in multidrug-resistant osteosarcoma cell linesShunan Ye, Jacson Shen, Edwin Choy, et al.
Discovery Medicine|December 10, 2015
The emerging roles and therapeutic potential of microRNAs (miRs) in liposarcomaRanran Sun, Jacson K Shen, Edwin Choy, et al.
The New England Journal of Medicine|August 25, 2016
CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 26-2016. A 28-Year-Old Woman with Back Pain and a Lesion in the Lumbar SpineEdwin Choy, Francis J Hornicek, Yen-Lin Chen, et al.
Cancer|October 19, 2011
High-throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide-3-kinase and other oncogenesEdwin Choy, Francis Hornicek, Laura MacConaill, et al.
Molecular Cancer Therapeutics|June 14, 2011
MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migrationZhenfeng Duan, Edwin Choy, David Harmon, et al.
Cancer Letters|January 26, 2016
Development and potential applications of CRISPR-Cas9 genome editing technology in sarcomaTang Liu, Jacson K Shen, Zhihong Li, et al.
The New England Journal of Medicine|October 23, 2014
Case records of the Massachusetts General Hospital. Case 33-2014. A 60-year-old man with bone painEdwin Choy, Eyal C Attar, Kevin S Oh, et al.
Molecular Cancer Therapeutics|October 1, 2010
Cyclin G-associated kinase is necessary for osteosarcoma cell proliferation and receptor traffickingMichiro Susa, Edwin Choy, Xianzhe Liu, et al.
Pageof 18